These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4790625)

  • 1. BL-20803, a new, low-molecular-weight interferon inducer.
    Siminoff P; Bernard AM; Hursky VS; Price KE
    Antimicrob Agents Chemother; 1973 Jun; 3(6):742-3. PubMed ID: 4790625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro stimulation of mouse spleen leukocytes by BL-20803, a low-molecular-weight interferon inducer.
    Siminoff P
    Infect Immun; 1975 Nov; 12(5):1051-7. PubMed ID: 1193723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new interferon inducer active via peroral administration].
    Ershov FI; Saĭitkulov AM; Tazulakhova EB; Sadykov AS
    Vopr Virusol; 1986; 31(3):335-8. PubMed ID: 2429451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies with low molecular weight inducers of interferon in man.
    Niblack JF
    Tex Rep Biol Med; 1977; 35():528-34. PubMed ID: 211671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the antiviral action of a new low-molecular interferon inducer].
    Shcherbakova EG; Furer NM; Rastunova GA; Litvinov AN; Zhigachev VE
    Antibiotiki; 1976 Sep; 21(9):838-42. PubMed ID: 187112
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of interferon production in mice and in mouse spleen leukocytes by analogues of BL-20803.
    Siminoff P; Crenshaw RR
    Antimicrob Agents Chemother; 1977 Mar; 11(3):571-3. PubMed ID: 856006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon inducing activities of derivatives of 1,3-dimethyl-4-(3-dimethylaminopropylamino)-1H-pyrazolo(3,4-b)quinoline and related compounds.
    Crenshaw RR; Luke GM; Siminoff P
    J Med Chem; 1976 Feb; 19(2):262-75. PubMed ID: 1249806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target cells for interferon induction by BL-20803.
    Siminoff P
    J Infect Dis; 1976 Jun; 133 Suppl():A37-42. PubMed ID: 932505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of interferon induction in albino mice by interferon inducer ridostin administered by various routes].
    Bulychev LE; Goncharova EP; Ryzhikov AB; Masycheva VI; P'iankova OG; Pliasunov IV; Poryvaev VD; Kotliarov LA; Kolesnikova NG
    Antibiot Khimioter; 1998; 43(4):20-3. PubMed ID: 9606500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing effects of the interferon inducer, avridine: enhancement or suppression of tumor growth depending on treatment regimen.
    Talcott PA; Koller LD; Woodard LF; Whitbeck GA
    Int J Immunopharmacol; 1986; 8(6):553-9. PubMed ID: 2432025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon inducers--from theory to practice].
    Spivak MIa; Karpov OV; Zholobak NM; Lazarenko LM; Tymoshok NO; Zotsenko VM; Hrabchenko NI; Hanova LO; Mykhaĭlenko OM
    Mikrobiol Z; 2003; 65(1-2):191-204. PubMed ID: 12774510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral induction of interferon by a low-molecular-weight compound.
    Soehner RL; Gambardella MM; Hou EF; Pollard M
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):1114-9. PubMed ID: 4362004
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interferon-inducing and anti-influenzal properties of 3-(2,2,2-trimethylhydrazine)propionate in an experiment].
    Kremerman IB; Priĭmiagi LS; Kal'vin'sh IIa; Lukevits EIa
    Vopr Virusol; 1987; 32(5):576-9. PubMed ID: 2448958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon induction via peroral administration of high-molecular polynucleotides].
    Grigorian SS; Ershov FI; Podgorodnichenko VK; Popov GA; Poverennyĭ AM
    Vopr Virusol; 1986; 31(3):338-42. PubMed ID: 2429452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
    Kern ER; Hamilton JR; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.
    Kraaijeveld CA; Snippe H; Harmsen T; Benaissa-Trouw B
    Cell Immunol; 1982 Dec; 74(2):277-83. PubMed ID: 6187475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interferon production by different inducers].
    Ershov FI; Nosik NN; Tazulakhova EB
    Biull Eksp Biol Med; 1983 Feb; 95(2):66-8. PubMed ID: 6186317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of interferon production from the enteral administration of inducers].
    Grigorian SS; Ershov FI; Poverennyĭ AM; Popov GA; Podgorodnichenko VK
    Vopr Virusol; 1988; 33(1):67-70. PubMed ID: 2453100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between interferon-inducing activity of natural interferon inducers and their chemical structure].
    Saĭitkulov AM; Ershov FI; Aslanov KhA; Tazupakhova EB; Maulianov SA; Achilova GSh; Amanova SKh
    Antibiot Khimioter; 1991 Jul; 36(7):39-42. PubMed ID: 1719947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of influenza virus and interferon response intranasally with statolon.
    Kleinschmidt WJ; Streightoff F
    Infect Immun; 1971 Dec; 4(6):738-41. PubMed ID: 5170549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.